GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
15 December 2009 - 3:29AM
PR Newswire (US)
SKIPPACK, Pa., Dec. 14 /PRNewswire/ -- At GeoInvesting.com, we have
been tracking Tianyin Pharmaceuticals (NYSE Amex: TPI) for some
time now. Our largest hang up had been with the potential dilution
from "in-the-money" warrants. Although the Company's fiscal June
2010 net income guidance of $11.3 million represents a 43.0%
increase from the fiscal 2009 reported net income of $7.9 million,
the increase in shares poses some uncertainty regarding the near
term EPS growth scenario, which depends upon the share price and
the Treasury method of accounting for these warrants under GAAP.
(Tianyin reported 32 cents per share for its 2009 fiscal year,
based on 24.8 million shares). Having said that, on December 3,
2009 Tianyin issued fiscal 2011 net income guidance of $19.6
million, implying earnings per share figure of 50 cents, fully
taxed. Combine this with an overall positive outlook, a very
accomplished management team, cash available to make potential
future acquisitions, and the TPI story begins to gain strength.
Biostar Pharmaceuticals (OTC:BSPM) (BULLETIN BOARD: BSPM) is
another pharmaceutical company whose stock we own. Through our
interview with management, BSPM demonstrated that it has a coherent
understanding of its markets and the steps necessary to accelerate
growth. Biostar manufactures & distributes 15 nonprescription,
prescription and nutraceutical products. There are 3 aspects of the
Company's story that are worth considering. First, Biostar's
Hepatitis flagship drug is the only one offered over the counter in
Chinese drug stores. To view more on TPI and BSPM , please visit
the following link:
http://geoinvesting.com/geowire/153/bright_future_for_two_china_pharma_pla
ys___nyse_amex_tpi____otcbb_bspm_ GeoInvesting.com Disclosure You
agree that you shall not republish or redistribute in any medium
any information on the GeoInvesting website without our express
written authorization. You acknowledge that GeoInvesting is not
registered as an exchange, broker-dealer or investment advisor
under any federal or state securities laws, and that GeoInvesting
has not provided you with any individualized investment advice or
information. Nothing in the website should be construed to be an
offer or sale of any security. You should consult your financial
advisor before making any investment decision or engaging in any
securities transaction as investing in any securities mentioned in
the website may or may not be suitable to you or for your
particular circumstances. GeoInvesting Contacts: Dan David, Vice
President Maj Soueidan, President Zou Soueidan, Equity Analyst Ph.
610-409-9297 Web site: http://www.geoinvesting.com/ DATASOURCE:
GeoInvesting.com CONTACT: Dan David, Vice President, or Maj
Soueidan, President, or Zou Soueidan, Equity Analyst, all of
GeoInvesting, +1-610-409-9297 Web Site:
http://www.geoinvesting.com/
Copyright